1Krant MJ, Manskopf G, Brandrui CS, et al.Immunologic alteration in bronchogenic cancer[J]. Cancer, 1968, 21(4) :623-631.
2Studnicka M, Wirnsberger R, Neumann M,et al. Peripheral blood lymphocyte subsets and survival in small cell lung cancer[ J ].Chest, 1994, 105(6) : 1673-1678.
3Mazzoccoli G, Balzanelli M. Lymphocyte subpopulations anomalies in lung cancer patients and relationship to the stage of disease[J]. In- Vivo, 1999, 13(3) :205-209.
4Arenberg DA, Keane MP, Digiovine B, et al. Macrophage infiltration in human nonsmall- cell lung cancer; the role of CC chemokines[ J ]. Cancer - Immunol - lmmunother, 2000, 49(2) : 63-70.
5Nowick A, Szenajch J, Ostrowska G, et al.Impaired tumor growth in CSF - 1 - deficient macrophage - deficient op; op mouse:evidence for a role of CSF- 1 - dependent macrophages in formation of tumor storma[J]. Int J Cancer, 1996,65 ( 1 ) : 112-119.
6Yano S, Nishioka Y, Izumi K, et al. Novel metastasis model of buman lung cancer in scid mice depleted of NK cells[ J ]. Int J Cancer, 1996, 67(2) :211-217.
7Asselin - Paturel G, Echchaldr H, Carayol G, et al. Quantative analylis of Th1, Th2 and TGF-β cytokine expression in tumor,TIL and PBL of non - small cell lung cancer patients[J]. Int J Cancer, 1998, 77(1) :7-12.
8Almand B, Resser JR, Lindman B, et al.Clinical significance of ddective dendritic cell differentiation in cancer[J]. Clin - Cancer - Res, 2000, 6(5) : 1755-1766.
9Klotz M, Blaces F, Funke D, et al. Shift in the IgG subclass distribution in patients with lung cancer[J]. Lung Cancer, 1999,24(1) :25-30.
10Tonda Y, IwanagaT, Vejima H, et al. Effects of cytokines on oxygen radical production by peripheral blood monocytes and alveoler macrophagea in patients with lung cancer[J]. Tumori, 1996, 82(4) : 382-385.
